News

openheart.bmj4d
OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic
Background Early in the COVID-19 pandemic, the National Health Service (NHS) recommended that appropriate patients anticoagulated with warfarin should be switched to direct-acting oral anticoagulants ...
openheart.bmj4d
Cardiac myosin inhibitors: a silver lining for an old disease
Hypertrophic cardiomyopathy (HCM), the most common inherited cardiovascular disease, accounts for a substantial number of cases of heart failure and sudden death.1 2 Resting or physiologically ...
openheart.bmj5d
Timing of oral anticoagulation in atrial fibrillation patients after acute ischaemic stroke and outcome after 3 months: results of the multicentre Berlin Atrial Fibrillation ...
Background Oral anticoagulation (OAC) is key in stroke prevention in patients with atrial fibrillation (AF) but there is uncertainty regarding the optimal timing of OAC (re)initiation after stroke, as ...
openheart.bmj6d
Management of patients with severe aortic stenosis in the TAVI-era: how recent recommendations are translated into clinical practice
Objective Approximately 3.4% of adults aged >75 years suffer from aortic stenosis (AS). Guideline indications for aortic valve replacement (AVR) distinguish between patients with symptomatic and ...